The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of PD-1 blockade using pembrolizumab in patients with advanced soft tissue (STS) and bone sarcomas (BS): Results of SARC028—A multicenter phase II study.
 
Hussein Abdul-Hassan Tawbi
Consulting or Advisory Role - Novartis
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst)
 
Melissa Amber Burgess
Travel, Accommodations, Expenses - Lilly
 
John Crowley
No Relationships to Disclose
 
Brian Andrew Van Tine
Consulting or Advisory Role - Advaxis; Caris Life Sciences; DFINE; EMD Serono; GlaxoSmithKline; Johnson & Johnson; Lilly/ImClone; Novartis; Threshold Pharmaceuticals
Speakers' Bureau - Caris Life Sciences; DFINE; GlaxoSmithKline
Research Funding - Morphotek; Polaris
 
James Hu
No Relationships to Disclose
 
Scott Schuetze
Honoraria - EMD Serono; EMD Serono; Janssen Research & Development
Consulting or Advisory Role - EMD Serono; EMD Serono; Janssen Research & Development
Research Funding - AB Science (Inst); Amgen (Inst); BioMed Valley Discoveries (Inst); CytRx Corporation (Inst); Janssen Research & Development (Inst); Plexxikon (Inst); Threshold Pharmaceuticals (Inst); ZIOPHARM Oncology (Inst)
Travel, Accommodations, Expenses - Amgen; BioMed Valley Discoveries; EMD Serono; Janssen Research & Development; Lilly
 
Sandra P. D'Angelo
Consulting or Advisory Role - Amgen; EMD Serono
 
Steven Attia
Consulting or Advisory Role - EMD Serono; Gradalis; Karyopharm Therapeutics
Research Funding - AB Science (Inst); Bayer (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); Morphotek (Inst); Novartis (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst); ZIOPHARM Oncology (Inst)
 
Dennis A. Priebat
No Relationships to Disclose
 
Scott H. Okuno
Consulting or Advisory Role - EMD Serono
 
Richard F. Riedel
Employment - Biotech Prosthetic Orthotics of North Carolina; Libbs
Leadership - Biotech Prosthetic Orthotics of North Carolina; Libbs
Stock and Other Ownership Interests - Biotech Prosthetic Orthotics of North Carolina; Libbs
Honoraria - Novartis
Consulting or Advisory Role - CytRx Corporation; Morphotek
Research Funding - Eisai (Inst); Merck (Inst); Novartis (Inst); Threshold Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Limbguard
 
Lara Emily Davis
Consulting or Advisory Role - Foundation Medicine
Patents, Royalties, Other Intellectual Property - Patent application filed for Target Inhibition Maps, a computational algorithm to predict tumor drug sensitivity. Co-inventor (5%)
 
Sujana Movva
No Relationships to Disclose
 
Damon R. Reed
Consulting or Advisory Role - EMD Serono
 
Laurence H. Baker
Consulting or Advisory Role - INC Research and Cyt RX; Marathon Pharma; Morphotek
 
Denise K. Reinke
Consulting or Advisory Role - Bayer; Tesaro; Threshold Pharmaceuticals
 
Robert G. Maki
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Janssen
Consulting or Advisory Role - Arcus Ventures; Bayer; Eisai; Gem Pharmaceuticals; Lilly/ImClone; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma
Research Funding - Epizyme (Inst); Immune Design (Inst); Lilly (Inst); Novartis (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - Bayer/Onyx; Janssen Oncology; TRACON Pharma
 
Shreyaskumar Patel
Consulting or Advisory Role - CytRx Corporation; Daiichi Sankyo; EMD Serono; Johnson & Johnson; Novartis
Research Funding - Eisai (Inst); Johnson & Johnson (Inst); Morphotek (Inst); PharmaMar (Inst)